[{"address1": "22211 West Interstate 10", "address2": "Suite 1206", "city": "San Antonio", "state": "TX", "zip": "78257", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 77, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 113750, "exercisedValue": 0, "unexercisedValue": 20135}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 67, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 299171, "exercisedValue": 0, "unexercisedValue": 20135}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vivienne I. Rebel M.D., Ph.D.", "age": 57, "title": "Executive VP and Chief Medical & Science Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 238390, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 70, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Senior Vice President of Therapeutics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.4, "open": 1.4, "dayLow": 1.36, "dayHigh": 1.4, "regularMarketPreviousClose": 1.4, "regularMarketOpen": 1.4, "regularMarketDayLow": 1.36, "regularMarketDayHigh": 1.4, "beta": 2.941, "forwardPE": -2.3083332, "volume": 13022, "regularMarketVolume": 13022, "averageVolume": 110648, "averageVolume10days": 51910, "averageDailyVolume10Day": 51910, "marketCap": 18627142, "fiftyTwoWeekLow": 0.955, "fiftyTwoWeekHigh": 3.62, "priceToSalesTrailing12Months": 2.5461235, "fiftyDayAverage": 2.07206, "twoHundredDayAverage": 1.957795, "currency": "USD", "enterpriseValue": 19407524, "profitMargins": -1.1941301, "floatShares": 8662338, "sharesOutstanding": 13449200, "sharesShort": 291910, "sharesShortPriorMonth": 603646, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0217, "heldPercentInsiders": 0.32506, "heldPercentInstitutions": 0.029719999, "shortRatio": 1.77, "shortPercentOfFloat": 0.037, "impliedSharesOutstanding": 13449200, "bookValue": 0.299, "priceToBook": 4.6321073, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -8736142, "trailingEps": -0.91, "forwardEps": -0.6, "enterpriseToRevenue": 2.653, "enterpriseToEbitda": -2.416, "52WeekChange": -0.18604654, "SandP52WeekChange": 0.24014747, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BIAF", "underlyingSymbol": "BIAF", "shortName": "bioAffinity Technologies, Inc.", "longName": "bioAffinity Technologies, Inc.", "firstTradeDateEpochUtc": 1662039000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "eaab05b5-2e95-3da9-8f74-9b1e2252e144", "messageBoardId": "finmb_423045573", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.385, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 801311, "totalCashPerShare": 0.06, "ebitda": -8034549, "totalDebt": 1380004, "quickRatio": 1.03, "currentRatio": 1.152, "totalRevenue": 7315883, "debtToEquity": 40.197, "revenuePerShare": 0.744, "returnOnAssets": -0.69784, "returnOnEquity": -1.5151801, "freeCashflow": -4287389, "operatingCashflow": -7027216, "revenueGrowth": 120.474, "grossMargins": 0.35473, "ebitdaMargins": -1.09823, "operatingMargins": -0.87077004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]